✨ Free AI Report
Seer Inc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Seer Inc
Company Research

Seer Inc: Business Overview, Financials & Competitive Analysis

Seer Inc scores 4/10 on the AskCyborg Cyborg Score (Mixed). Early-stage proteomics platform with validated science and strong balance sheet, but requires sustained revenue acceleration to justify valuation. Q3 2025 revenue was $4.1 million (up 2% YoY) with 51% gross margin, but operating expenses were $21.5 million with a net loss of $18.2 million. The company maintains strong cash position.

What is Seer Inc's industry? Seer Inc (seer.bio) operates in Life Sciences / Proteomics Technology. AskCyborg classifies Seer Inc under Life Sciences / Proteomics Technology in its company registry.

Seer Inc is a life sciences company that develops and commercializes the Proteograph Product Suite, an integrated solution including proprietary engineered nanoparticles, consumables, automation instrumentation, and d...

4/ 10Mixed

Cyborg Score thesis

Early-stage proteomics platform with validated science and strong balance sheet, but requires sustained revenue acceleration to...

Read the full analyst-debate transcript →
Industry Life Sciences / Proteomics Technology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Seer Inc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Seer Inc

AskCyborg analysts argue the bull and bear cases for Seer Inc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Seer Inc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Seer Inc Overview

Pro stress-test →

Seer Inc is a life sciences company that develops and commercializes the Proteograph Product Suite, an integrated solution including proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis. The company enables researchers to decode biology at the protein level, addressing a critical gap in precision medicine research.

Strategic Profile

Pro stress-test →

Seer markets its products for research use only to academic institutions, life sciences and research laboratories, and biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company has validated its Proteograph product suite for population-scale, peptide-level mass spectrometry proteomics through a Nature Genetics study, strengthening its competitive positioning in the emerging proteomics space.

Competitive Landscape

Pro stress-test →

Seer competes in the emerging proteomics market against established life science tool providers (Thermo Fisher, Waters Corporation) and specialized proteomics companies. Seer's differentiation lies in its proprietary nanoparticle technology enabling rapid, unbiased protein detection at scale. Competition intensifies as major instrument manufacturers expand proteomics offerings.

Industry Context

Seer Inc operates in Life Sciences / Proteomics Technology.

Key facts

Founded: 2017 · Headquarters: Redwood City, California · Revenue: $4.1M (Q3 2025) · Market cap: $136M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Seer Inc.

  • Nearly three times more instrument shipments year-to-date vs. 2024 and a record >60 third-party publications indicate growing adoption and validation
  • Full-year 2025 revenue guidance of $17–$18 million represents midpoint +24% growth vs. 2024
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026Q4 2025 financial results reported
  • Nov 2025Nature Genetics publication validating Proteograph for population-scale proteomics
  • +1 moreTrack every material event for Seer Inc as it happens. Explore monitoring →
Get alerted when Seer Inc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Mass Spectrometry PlatformsBroad life sciences instrument portfolio including proteomics capabilities→Proteomics PlatformsAnalytical instrument manufacturer with chromatography and mass spectrometry solutions→Emerging Proteomics CompetitorsAlternative proteomics platform using different technology approaches→

Compare Seer Inc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Seer Inc operates in Life Sciences / Proteomics Technology. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences / Proteomics Technology research →
NEW · MCP server

Ask your AI assistant about Seer Inc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Seer Inc and its top competitor on Cyborg Score”
“What did Seer Inc do this quarter?”
“Is Seer Inc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Seer Inc do?+
Seer Inc is a life sciences company that develops and commercializes the Proteograph Product Suite, an integrated solution including proprietary engineered nanoparticles, consumables, automation instrumentation, and d...
What is Seer Inc's Cyborg Score?+
Seer Inc has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Seer Inc's main competitors?+
Named competitors include Mass Spectrometry Platforms, Proteomics Platforms, Emerging Proteomics Competitors. The full competitive landscape is in the AskCyborg report.
How can I get the full Seer Inc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Seer Inc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Seer Inc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Life Sciences research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Danaher Corporation8Thermo Fisher Scientific Inc.7Repligen Corporation6iSpecimen Inc.6Nautilus Biotechnology, Inc.6Quanterix Corporation